Alpha 2.0

» Articles » PMID: 36555866

Hypertriglyceridemia and Atherosclerotic Carotid Artery Stenosis

Overview

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Dec 23

PMID 36555866

Authors

Authors

Yoichi Miura

Hidenori Suzuki

Affiliations

Affiliations

Soon will be listed here.

Abstract

Both fasting and non-fasting hypertriglyceridemia have emerged as residual risk factors for atherosclerotic disease. However, it is unclear whether hypertriglyceridemia increases the risks of the progression of carotid artery stenosis. Statins are well known to prevent carotid plaque progression and improve carotid plaque instability. In addition, statin therapy is also known to reduce cerebrovascular events in patients with carotid artery stenosis and to improve clinical outcomes in patients undergoing revascularization procedures. On the other hand, there have been no randomized controlled trials showing that the combination of non-statin lipid-lowering drugs with statins has additional beneficial effects over statin monotherapy to prevent cerebrovascular events and stenosis progression in patients with carotid artery stenosis. In this article, the authors demonstrate the mechanisms of atherosclerosis formation associated with hypertriglyceridemia and the potential role of lipid-lowering drugs on carotid artery stenosis. The authors also review the articles reporting the relationships between hypertriglyceridemia and carotid artery stenosis.

Citing Articles

Association between triglyceride to high-density lipoprotein cholesterol ratio and microalbuminuria in the Chinese population.

Zhang X, Hu H, He L, Huang X, Zhang Z, Tu L Sci Rep. 2024; 14(1):30960.

PMID: 39730606 PMC: 11680801. DOI: 10.1038/s41598-024-82084-5.

Association between triglycerides and lumbar bone mineral density in Chinese patients with osteoporotic fractures: a retrospective cross-sectional study.

Zhou P, Liu L, Lu K, Xu M, Ye Y, Li C Sci Rep. 2024; 14(1):29473.

PMID: 39604402 PMC: 11603138. DOI: 10.1038/s41598-024-78926-x.

The role of lipase maturation factor 1 in hypertriglyceridaemia and atherosclerosis: An update.

Dabravolski S, Churov A, Sukhorukov V, Kovyanova T, Beloyartsev D, Lyapina I SAGE Open Med. 2024; 12:20503121241289828.

PMID: 39483624 PMC: 11526315. DOI: 10.1177/20503121241289828.

Exploring Gender Disparities in the Prevalence and Clinical Characteristics of Atherosclerotic Cranial Stenosis.

Alqahtani S Cureus. 2023; 15(9):e45809.

PMID: 37745741 PMC: 10517424. DOI: 10.7759/cureus.45809.

The role of TLR2 in exercise-induced immunomodulation in normal weight individuals.

Bahman F, Alsaeed H, Albeloushi S, Al-Mulla F, Ahmad R, Al-Rashed F Sci Rep. 2023; 13(1):10703.

PMID: 37400578 PMC: 10318094. DOI: 10.1038/s41598-023-37811-9.

References

1.

Kolovou G, Kostakou P, Anagnostopoulou K, Cokkinos D . Therapeutic effects of fibrates in postprandial lipemia. Am J Cardiovasc Drugs. 2008; 8(4):243-55. DOI: 10.2165/00129784-200808040-00004. View

2.

Masuda D, Sakai N, Sugimoto T, Kitazume-Taneike R, Yamashita T, Kawase R . Fasting serum apolipoprotein B-48 can be a marker of postprandial hyperlipidemia. J Atheroscler Thromb. 2011; 18(12):1062-70. DOI: 10.5551/jat.10470. View

3.

Vanschoonbeek K, Feijge M, Saris W, de Maat M, Heemskerk J . Plasma triacylglycerol and coagulation factor concentrations predict the anticoagulant effect of dietary fish oil in overweight subjects. J Nutr. 2006; 137(1):7-13. DOI: 10.1093/jn/137.1.7. View

4.

OKeefe Jr J, Harris W, Nelson J, Windsor S . Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia. Am J Cardiol. 1995; 76(7):480-4. DOI: 10.1016/s0002-9149(99)80134-9. View

5.

Norata G, Tsimikas S, Pirillo A, Catapano A . Apolipoprotein C-III: From Pathophysiology to Pharmacology. Trends Pharmacol Sci. 2015; 36(10):675-687. DOI: 10.1016/j.tips.2015.07.001. View

6.

Hogue J, Lamarche B, Deshaies Y, Tremblay A, Bergeron J, Gagne C . Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia. Metabolism. 2008; 57(2):246-54. DOI: 10.1016/j.metabol.2007.09.008. View

7.

Chan D, Watts G, Barrett P, Martins I, James A, Mamo J . Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test. J Lipid Res. 2002; 43(5):706-12. View

8.

Tanaka H, Zaima N, Ito H, Hattori K, Yamamoto N, Konno H . Cilostazol inhibits accumulation of triglycerides in a rat model of carotid artery ligation. J Vasc Surg. 2013; 58(5):1366-74. DOI: 10.1016/j.jvs.2013.01.033. View

9.

Wolf P, OLeary D, Poehlman H, Belanger A, Kase C, DAgostino R . Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology. 1994; 44(6):1046-50. DOI: 10.1212/wnl.44.6.1046. View

10.

Zaima N, Sasaki T, Tanaka H, Cheng X, Onoue K, Hayasaka T . Imaging mass spectrometry-based histopathologic examination of atherosclerotic lesions. Atherosclerosis. 2011; 217(2):427-32. DOI: 10.1016/j.atherosclerosis.2011.03.044. View

11.

Kastelein J, Akdim F, Stroes E, Zwinderman A, Bots M, Stalenhoef A . Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008; 358(14):1431-43. DOI: 10.1056/NEJMoa0800742. View

12.

Kamstrup P, Tybjaerg-Hansen A, Nordestgaard B . Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J Am Coll Cardiol. 2013; 63(5):470-7. DOI: 10.1016/j.jacc.2013.09.038. View

13.

Labreuche J, Deplanque D, Touboul P, Bruckert E, Amarenco P . Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis: systematic review and meta-regression analysis. Atherosclerosis. 2010; 212(1):9-15. DOI: 10.1016/j.atherosclerosis.2010.02.011. View

14.

den Ruijter H, Peters S, Anderson T, Britton A, Dekker J, Eijkemans M . Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012; 308(8):796-803. DOI: 10.1001/jama.2012.9630. View

15.

Nordestgaard B, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E . Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European.... Eur Heart J. 2016; 37(25):1944-58. PMC: 4929379. DOI: 10.1093/eurheartj/ehw152. View

16.

Jun M, Foote C, Lv J, Neal B, Patel A, Nicholls S . Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet. 2010; 375(9729):1875-84. DOI: 10.1016/S0140-6736(10)60656-3. View

17.

Nordestgaard B, Benn M, Schnohr P, Tybjaerg-Hansen A . Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007; 298(3):299-308. DOI: 10.1001/jama.298.3.299. View

18.

Reiff T, Eckstein H, Mansmann U, Jansen O, Fraedrich G, Mudra H . Successful implementation of best medical treatment for patients with asymptomatic carotid artery stenosis within a randomized controlled trial (SPACE-2). Neurol Res Pract. 2021; 3(1):62. PMC: 8524978. DOI: 10.1186/s42466-021-00153-w. View

19.

Masuda D, Yamashita S . Postprandial Hyperlipidemia and Remnant Lipoproteins. J Atheroscler Thromb. 2016; 24(2):95-109. PMC: 5305681. DOI: 10.5551/jat.RV16003. View

20.

Fogelstrand P, Boren J . Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis. Nutr Metab Cardiovasc Dis. 2011; 22(1):1-7. DOI: 10.1016/j.numecd.2011.09.007. View